The Vienna Brain Metastasis Registry identified BC patients with BM between 1992 and 2020, categorised by subtype: hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−), HER2 overexpressing (HER2+), and triple-negative (TN). The gene discussed is NR4A1; the disease is breast cancer.